Head-to-head · Value Score
CoreAge Rx vs Piper
Two GLP-1 deals, scored on the same six factors. CoreAge Rx lands a Value Score of 93, Piper a 84. Here's who gives you the honest lower price — and where each one bites back.
CoreAge Rx
#1 · Grade A+ · Best Value
Est. first month
$99/mo
Save ~89% vs brand-namePiper
#31 · Grade B+ · Good Value
Est. first month
From $135/mo (starting dose, compounded)
Save ~90% vs brand-nameThe verdict
CoreAge Rx takes it on Value Score, 93 to 84 — an est. $99/mo first month, with no teaser step-up baked in. Piper isn't out of it: Someone comparing on the entry price who will confirm what the rate becomes at a full maintenance dose before committing.
CoreAge Rx is also our overall #1 pick across the whole deals ranking — a flat, all-in price on both molecules in all 50 states. That's why it wins here on the score, not just this matchup.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | CoreAge Rx | Piper |
|---|---|---|
| Value Score | 93 (A+) | 84 (B+) |
| Est. first month | $99/mo | From $135/mo (starting dose, compounded) |
| Save vs brand-name | ~89% | ~90% |
| Semaglutide | $99/mo | From $135/mo (starting dose, compounded) |
| Tirzepatide | $149/mo | From $199/mo (starting dose, compounded) |
| Both molecules | Yes | Yes |
| Pricing | Flat — no step-up | Watch |
| Coverage | All 50 states | All 50 states |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
CoreAge Rx
The honest lowest price: both molecules at one flat, all-in monthly rate that never steps up after month one.
Why it's a deal
- Flat, all-in monthly price with no intro-rate step-ups after month one
- Both compounded semaglutide and tirzepatide on one account
- Available in all 50 states
- Straightforward, low-friction cancellation — no lock-in
The fine print
- Not the rock-bottom sticker — a couple of teaser tiers advertise lower month-one rates
- No FDA-approved brand-name option (compounded only)
- Does not yet publicly name its 503A/B pharmacy partner
Piper
Now trading as Polly, with two named compounding pharmacies, next-day shipping and no membership fee - but the advertised rate is a starting-dose price, so the number that matters is the one at your dose.
Why it's a deal
- Names both of its compounding pharmacies - Hallandale Pharmacy and VialsRx - which most sellers at this price do not
- No membership fee and no separate charges advertised, with free next-day air shipping
- Both compounded semaglutide and tirzepatide, with providers available in all 50 states
- Same-day doctor visits and ongoing provider support through the patient portal
The fine print
- The advertised price is a starting-dose rate, so what matters is what it becomes at a maintenance dose
- The brand renamed from Piper to Polly, so the company you researched and the site you land on now carry different names - worth knowing before you hand over a card
- Publishes no cancellation terms or notice period on its home page
- Its home page does not carry the plain statement most rivals make, that compounded medication is not FDA-approved
- Compounded injectable only - no brand-name or oral route
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
Neither one the right fit? Every program that outscores CoreAge Rx is ranked on the CoreAge Rx alternatives ranking, and the same list for the other side is on alternatives to Piper.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.